Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals
  • Print
  • Share
  • E-mail
-
Generic Name: Rifampin, isoniazid, pyrazinamide
Trade Name: Rifater
Date Designated: 09/12/1985
Orphan Designation: For the short-course treatment of tuberculosis.
Orphan Designation Status: Designated/Approved
Hoechst Marion Roussel
P.O. Box 9627
Kansas City, Missouri 64134
United States

The sponsor address listed is the last reported by the sponsor to OOPD.

Marketing approved:

1 Generic Name: Rifampin, isoniazid, pyrazinamide
Trade Name: Rifater
Marketing Approval Date: 05/31/1994
Approved Labeled Indication: Short-course treatment of tuberculosis.
Exclusivity End Date: 05/31/2001 
Exclusivity Protected Indication* :  
*Exclusivity Protected Indications are shown for approvals from 01/01/2013 to the present.
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-
-